Literature DB >> 18978528

Gram-negative sepsis in the intensive care unit: avoiding therapeutic failure.

Scott Chapman1, Jonathan R Iredell.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to examine some of the latest concepts in the management of sepsis and septic shock in the Intensive Care environment, with a focus on Gram-negative infections. RECENT
FINDINGS: Recent developments in adjunctive therapies for sepsis and septic shock are discussed including protocol-driven therapies, the importance of timely appropriate antimicrobials and the growing threat and implications of rising Gram-negative antimicrobial resistance.
SUMMARY: The balance between the most effective and the most responsible prescribing is difficult to strike, but recognition of the impact of antibiotic failure makes it even more important to consider how we husband the microflora of the ICU. New therapeutic options are somewhat limited but goal-directed protocol-driven approaches linked with sound knowledge of the microflora and our impact upon it as an ecosystem is essential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18978528     DOI: 10.1097/QCO.0b013e328319ea67

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  2 in total

1.  Lipid A-based affinity biosensor for screening anti-sepsis components from herbs.

Authors:  Jie Yao; Yiguo Chen; Ning Wang; Dongneng Jiang; Jiang Zheng
Journal:  Biosci Rep       Date:  2014-05-23       Impact factor: 3.840

2.  Validation of Rapid Antimicrobial Susceptibility Testing directly from blood cultures using WASPLab®, including Colibrí and Radian® in-Line Carousel.

Authors:  Pauline Hilda Herroelen; Robbe Heestermans; Kristof Emmerechts; Kristof Vandoorslaer; Ingrid Wybo; Denis Piérard; Astrid Muyldermans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-02-25       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.